407 related articles for article (PubMed ID: 19830760)
1. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
[TBL] [Abstract][Full Text] [Related]
2. A Fluorescent sp2-iminosugar with pharmacological chaperone activity for gaucher disease: synthesis and intracellular distribution studies.
Luan Z; Higaki K; Aguilar-Moncayo M; Li L; Ninomiya H; Nanba E; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2010 Nov; 11(17):2453-64. PubMed ID: 21064079
[TBL] [Abstract][Full Text] [Related]
3. Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.
Yu L; Ikeda K; Kato A; Adachi I; Godin G; Compain P; Martin O; Asano N
Bioorg Med Chem; 2006 Dec; 14(23):7736-44. PubMed ID: 16919960
[TBL] [Abstract][Full Text] [Related]
4. Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Sawkar AR; Cheng WC; Beutler E; Wong CH; Balch WE; Kelly JW
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15428-33. PubMed ID: 12434014
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin-mediated crystallization of acid β-glucosidase in complex with amphiphilic bicyclic nojirimycin analogues.
Brumshtein B; Aguilar-Moncayo M; Benito JM; García Fernandez JM; Silman I; Shaaltiel Y; Aviezer D; Sussman JL; Futerman AH; Ortiz Mellet C
Org Biomol Chem; 2011 Jun; 9(11):4160-7. PubMed ID: 21483943
[TBL] [Abstract][Full Text] [Related]
6. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
7. Promising results of the chaperone effect caused by imino sugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease.
Sánchez-Ollé G; Duque J; Egido-Gabás M; Casas J; Lluch M; Chabás A; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2009; 42(2):159-66. PubMed ID: 19167250
[TBL] [Abstract][Full Text] [Related]
8. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
[TBL] [Abstract][Full Text] [Related]
9. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW
Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303
[TBL] [Abstract][Full Text] [Related]
10. Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
Diot JD; Garcia Moreno I; Twigg G; Ortiz Mellet C; Haupt K; Butters TD; Kovensky J; Gouin SG
J Org Chem; 2011 Oct; 76(19):7757-68. PubMed ID: 21830816
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
Wang GN; Twigg G; Butters TD; Zhang S; Zhang L; Zhang LH; Ye XS
Org Biomol Chem; 2012 Apr; 10(15):2923-7. PubMed ID: 22286559
[TBL] [Abstract][Full Text] [Related]
12. Probing the Inhibitor versus Chaperone Properties of sp²-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease.
Mena-Barragán T; García-Moreno MI; Sevšek A; Okazaki T; Nanba E; Higaki K; Martin NI; Pieters RJ; Fernández JMG; Mellet CO
Molecules; 2018 Apr; 23(4):. PubMed ID: 29673163
[TBL] [Abstract][Full Text] [Related]
13. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
Cheng WC; Weng CY; Yun WY; Chang SY; Lin YC; Tsai FJ; Huang FY; Chen YR
Bioorg Med Chem; 2013 Sep; 21(17):5021-8. PubMed ID: 23880081
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
Brumshtein B; Greenblatt HM; Butters TD; Shaaltiel Y; Aviezer D; Silman I; Futerman AH; Sussman JL
J Biol Chem; 2007 Sep; 282(39):29052-29058. PubMed ID: 17666401
[TBL] [Abstract][Full Text] [Related]
15. Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.
Serra-Vinardell J; Díaz L; Gutiérrez-de Terán H; Sánchez-Ollé G; Bujons J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Grinberg D; Vilageliu L; Casas J
Int J Biochem Cell Biol; 2014 Sep; 54():245-54. PubMed ID: 25084554
[TBL] [Abstract][Full Text] [Related]
16. A comparative computational approach toward pharmacological chaperones (NN-DNJ and ambroxol) on N370S and L444P mutations causing Gaucher's disease.
Thirumal Kumar D; Iyer S; Christy JP; Siva R; Tayubi IA; George Priya Doss C; Zayed H
Adv Protein Chem Struct Biol; 2019; 114():315-339. PubMed ID: 30635084
[TBL] [Abstract][Full Text] [Related]
17. Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase.
Aguilar-Moncayo M; García-Moreno MI; Trapero A; Egido-Gabás M; Llebaria A; Fernández JM; Mellet CO
Org Biomol Chem; 2011 May; 9(10):3698-713. PubMed ID: 21451818
[TBL] [Abstract][Full Text] [Related]
18. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
[TBL] [Abstract][Full Text] [Related]
19. Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants.
Sawkar AR; Schmitz M; Zimmer KP; Reczek D; Edmunds T; Balch WE; Kelly JW
ACS Chem Biol; 2006 May; 1(4):235-51. PubMed ID: 17163678
[TBL] [Abstract][Full Text] [Related]
20. 6-Amino-6-deoxy-5,6-di-N-(N'-octyliminomethylidene)nojirimycin: synthesis, biological evaluation, and crystal structure in complex with acid beta-glucosidase.
Brumshtein B; Aguilar-Moncayo M; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Silman I; Shaaltiel Y; Aviezer D; Sussman JL; Futerman AH
Chembiochem; 2009 Jun; 10(9):1480-5. PubMed ID: 19437524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
